Evidence map›Paper›PMID 30368077›Full record

ArticleiScience2018

AMP-Activated Protein Kinase Is Essential for the Maintenance of Energy Levels during Synaptic Activation.

Claudia Marinangeli, Sébastien Didier, Tariq Ahmed, Raphaelle Caillerez, Manon Domise, Charlotte Laloux, Séverine Bégard, Sébastien Carrier, Morvane Colin, Philippe Marchetti and 5 more

Open access · goldAbstract read
In one paragraph

Article in iScience, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 84 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 4 countries.

Claudia MarinangeliUniv. Lille, Inserm, CHU-Lille, UMR-S1172, Jean-Pierre Aubert Research Centre, Bâtiment Biserte, Place de Verdun, Lille 59045, France.
Sébastien DidierUniv. Lille, Inserm, CHU-Lille, UMR-S1172, Jean-Pierre Aubert Research Centre, Bâtiment Biserte, Place de Verdun, Lille 59045, France.
Tariq AhmedBrain & Cognition, Faculty of Psychology and Educational Sciences, KU Leuven, Leuven, Belgium; Leuven Research Institute for Neuroscience & Disease (LIND), KU Leuven, Leuven, Belgium; Neurological Disorders Research Center, Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University, Doha, Qatar.
Raphaelle CaillerezUniv. Lille, Inserm, CHU-Lille, UMR-S1172, Jean-Pierre Aubert Research Centre, Bâtiment Biserte, Place de Verdun, Lille 59045, France.
Manon DomiseUniv. Lille, Inserm, CHU-Lille, UMR-S1172, Jean-Pierre Aubert Research Centre, Bâtiment Biserte, Place de Verdun, Lille 59045, France.
Charlotte LalouxUniv. Lille, Lille Neurosciences, SFR DN2M, Lille 59000, France.
Séverine BégardUniv. Lille, Inserm, CHU-Lille, UMR-S1172, Jean-Pierre Aubert Research Centre, Bâtiment Biserte, Place de Verdun, Lille 59045, France.
Sébastien CarrierUniv. Lille, Inserm, CHU-Lille, UMR-S1172, Jean-Pierre Aubert Research Centre, Bâtiment Biserte, Place de Verdun, Lille 59045, France.
Morvane ColinUniv. Lille, Inserm, CHU-Lille, UMR-S1172, Jean-Pierre Aubert Research Centre, Bâtiment Biserte, Place de Verdun, Lille 59045, France.
Philippe MarchettiUniv. Lille, Inserm, CHU-Lille, UMR-S1172, Jean-Pierre Aubert Research Centre, Bâtiment Biserte, Place de Verdun, Lille 59045, France.
Bart GhesquièreVIB Center for Cancer Biology, KU Leuven, Department of Oncology, Leuven 3000, Belgium.
Detlef BalschunBrain & Cognition, Faculty of Psychology and Educational Sciences, KU Leuven, Leuven, Belgium; Leuven Research Institute for Neuroscience & Disease (LIND), KU Leuven, Leuven, Belgium.
Luc BuéeUniv. Lille, Inserm, CHU-Lille, UMR-S1172, Jean-Pierre Aubert Research Centre, Bâtiment Biserte, Place de Verdun, Lille 59045, France.
Jérôme KluzaUniv. Lille, Inserm, CHU-Lille, UMR-S1172, Jean-Pierre Aubert Research Centre, Bâtiment Biserte, Place de Verdun, Lille 59045, France.
Valérie VingtdeuxUniv. Lille, Inserm, CHU-Lille, UMR-S1172, Jean-Pierre Aubert Research Centre, Bâtiment Biserte, Place de Verdun, Lille 59045, France. Electronic address: valerie.vingtdeux@inserm.fr.
Inserm · FRAllen Institute for Brain Science · USUniversité de Lille · FRVIB-KU Leuven Center for Brain & Disease Research · BEVIB-KU Leuven Center for Cancer Biology · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although the brain accounts for only 2% of the total body mass, it consumes the most energy. Neuronal metabolism is tightly controlled, but it remains poorly understood how neurons meet their energy demands to sustain synaptic transmission. Here we provide evidence that AMP-activated protein kinase (AMPK) is pivotal to sustain neuronal energy levels upon synaptic activation by adapting the rate of glycolysis and mitochondrial respiration. Furthermore, this metabolic plasticity is required for the expression of immediate-early genes, synaptic plasticity, and memory formation. Important in this context, in neurodegenerative disorders such as Alzheimer disease, dysregulation of AMPK impairs the metabolic response to synaptic activation and processes that are central to neuronal plasticity. Altogether, our data provide proof of concept that AMPK is an essential player in the regulation of neuroenergetic metabolic plasticity induced in response to synaptic activation and that its deregulation might lead to cognitive impairments.

Indexed as

Cellular NeuroscienceMolecular NeuroscienceNeuroscience

Identifiers

PMID30368077
PMCPMC6203244
OpenAlexW2951104254

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.